CIK 0001840229 · <br>Emerging growth company
MiNK Therapeutics, Inc.
Sign in to watch- Ticker
- INKT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 212-994-8250
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $73,265
- in 1 filing
Net −$73,265. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 30 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | Corvese Brian Director | Grant or award | +18,816 | $0.95 | $18K | 365,527 |
| 2024-01-16 | Buell Jennifer Chief Executive Officer | Grant or award · Stock Option | +500,000 | 500,000 | ||
| 2024-01-16 | Buell Jennifer Chief Executive Officer | Grant or award · Stock Option | +660,919 | 660,919 | ||
| 2024-01-16 | van Dijk Marcus Antonius Chief Scientific Officer | Grant or award · Stock Option | +15,000 | 15,000 | ||
| 2024-01-16 | van Dijk Marcus Antonius Chief Scientific Officer | Grant or award · Stock Option | +171,078 | 171,078 | ||
| 2023-12-01 | Ryan Barbara Director | Grant or award | +17,068 | $1.04 | $18K | 67,932 |
| 2023-12-01 | Corvese Brian Director | Grant or award | +17,188 | $1.04 | $18K | 346,711 |
| 2023-12-01 | WIINBERG ULF Director | Grant or award | +14,424 | $1.04 | $15K | 74,543 |
| 2023-12-01 | Behner Peter Director | Grant or award | +14,784 | $1.04 | $15K | 58,842 |
| 2023-10-16 | AGENUS INC 10% owner | Purchase | +429 | $1.10 | $472 | 21,772,863 |
| 2023-10-13 | AGENUS INC 10% owner | Purchase | +19,373 | $1.10 | $21K | 21,772,434 |
| 2023-10-12 | AGENUS INC 10% owner | Purchase | +3,173 | $1.10 | $3K | 21,753,061 |
| 2023-10-11 | Buell Jennifer Chief Executive Officer | Other disposition | −695,750 | 232,165 | ||
| 2023-10-11 | Buell Jennifer Chief Executive Officer | Grant or award · Restricted Stock Units | −695,750 | 0 | ||
| 2023-10-04 | AGENUS INC 10% owner | Purchase | +15,001 | $1.09 | $16K | 21,749,888 |
| 2023-10-03 | Buell Jennifer Chief Executive Officer | Shares withheld for taxes | −65,000 | $0.94 | $61K | 927,915 |
| 2023-10-02 | Buell Jennifer Chief Executive Officer | Shares withheld for taxes | −58,550 | $1.04 | $61K | 992,915 |
| 2023-09-29 | Buell Jennifer Chief Executive Officer | Shares withheld for taxes | −25,000 | $1.15 | $29K | 1,051,465 |
| 2023-09-27 | Buell Jennifer Chief Executive Officer | Option exercise | +695,750 | 1,076,465 | ||
| 2023-09-27 | Buell Jennifer Chief Executive Officer | Option exercise · Restricted Stock Unit | −695,750 | 695,750 |
Page 5 of 7 · 126 trades